Crystal structure and isomerism of a tumour targeting radiopharmaceutical: [ReO(dmsa)2]–(H2dmsa =meso-2,3-dimercaptosuccinic acid)
Authors:
- Jaspal SinghJSJaspal Singh
- Anne K. PowellAPAnne K. Powell
- Susan E. M. ClarkeSCSusan E. M. Clarke
- Philip J. BlowerPBPhilip J. Blower
- 1 January 1991
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Chemical Communications
- No. 16,p. 1115-1117
Abstract
A crystal structure determination shows that one isomer of the complex anion [ReO(dmsa)2]–(H2dmsa =meso-2,3-dimercaptosuccinic acid), a compound which in radiopharmaceutical form has been shown to localise in certain human tumours, has a square-pyramidal structure with all carboxylic acid groups uncoordinated and oriented endo relative to the oxo ligand.Keywords
This publication has 3 references indexed in Scilit:
- Synthesis and characterization of [186Re]rhenium(V)dimercaptosuccinic acid: A possible tumour radiotherapy agentInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- Rhenium complexes with di- and tri-thiolate ligands. The synthesis and X-ray crystal structures of square pyramidal [PPh4][ReO(SCH2CH2S)2] and [NMe4][ReS(SCH2CH2S)2] and trigonal prismatic [PPh4][Re{(SCH2)3CCH3}2]J. Chem. Soc., Dalton Trans., 1986
- Synthesis and X-ray crystal structure of tetraethylammonium bis[1,2-di(carbomethoxy)ethane-1,2-dithiolato]oxotechnetate(V)Transition Metal Chemistry, 1984